BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16051244)

  • 1. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.
    Haldorson GJ; Mathison BA; Wenberg K; Conrad PA; Dubey JP; Trees AJ; Yamane I; Baszler TV
    Int J Parasitol; 2005 Nov; 35(13):1407-15. PubMed ID: 16051244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 response to NcSRS2 immunization of BALB/c mice against Neospora caninum.
    Gonçalves KN; Andreotti R; Paiva F; Pontes ER; Lima Junior MS; Matos LM
    Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():215-9. PubMed ID: 20059851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
    Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
    Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
    Tuo W; Zhao Y; Zhu D; Jenkins MC
    Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum.
    Liddell S; Parker C; Vinyard B; Jenkins M; Dubey JP
    J Parasitol; 2003 Jun; 89(3):496-500. PubMed ID: 12880248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a DNA vaccine expressing the Neospora caninum surface protein NcSRS2 in mice.
    Zhao Z; Ding J; Liu Q; Wang M; Yu J; Zhang W
    Acta Vet Hung; 2009 Mar; 57(1):51-62. PubMed ID: 19457773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.
    Pinitkiatisakul S; Friedman M; Wikman M; Mattsson JG; Lövgren-Bengtsson K; Ståhl S; Lundén A
    Vaccine; 2007 May; 25(18):3658-68. PubMed ID: 17280751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.
    Staska LM; Davies CJ; Brown WC; McGuire TC; Suarez CE; Park JY; Mathison BA; Abbott JR; Baszler TV
    Infect Immun; 2005 Mar; 73(3):1321-9. PubMed ID: 15731029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of immunization with inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against neosporosis in mice.
    Rojo-Montejo S; Collantes-Fernández E; Rodríguez-Marcos S; Pérez-Zaballos F; López-Pérez I; Prenafeta A; Ortega-Mora LM
    Parasitology; 2011 Sep; 138(11):1372-83. PubMed ID: 21810300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
    Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
    Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.
    Moore DP; Leunda MR; Zamorano PI; Odeón AC; Romera SA; Cano A; de Yaniz G; Venturini MC; Campero CM
    Vet Parasitol; 2005 Jun; 130(1-2):29-39. PubMed ID: 15893067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2.
    Pinheiro AF; Roloff BC; da Silveira Moreira A; Berne MEA; Silva RA; Leite FPL
    Vaccine; 2018 Feb; 36(9):1154-1159. PubMed ID: 29395519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of parasite DNA in the blood of immunized and naïve mice after infection with Neospora caninum.
    Pinitkiatisakul S; Mattsson JG; Lundén A
    Parasitology; 2008 Feb; 135(2):175-82. PubMed ID: 17922929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice.
    Zhang H; Nishikawa Y; Yamagishi J; Zhou J; Ikehara Y; Kojima N; Yokoyama N; Xuan X
    Exp Parasitol; 2010 Jun; 125(2):130-6. PubMed ID: 20097198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine immune response to inoculation with Neospora caninum surface antigen SRS2 lipopeptides mimics immune response to infection with live parasites.
    Baszler TV; Shkap V; Mwangi W; Davies CJ; Mathison BA; Mazuz M; Resnikov D; Fish L; Leibovitch B; Staska LM; Savitsky I
    Clin Vaccine Immunol; 2008 Apr; 15(4):659-67. PubMed ID: 18305105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of recombinant Neospora caninum antigens purified from silkworm larvae for the protection of N. caninum infection in mice.
    Yoshimoto M; Otsuki T; Itagaki K; Kato T; Kohsaka T; Matsumoto Y; Ike K; Park EY
    J Biosci Bioeng; 2015 Dec; 120(6):715-9. PubMed ID: 25935502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
    Srinivasan S; Mueller J; Suana A; Hemphill A
    J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms.
    Pinitkiatisakul S; Mattsson JG; Wikman M; Friedman M; Bengtsson KL; Ståhl S; Lundén A
    Vet Parasitol; 2005 Apr; 129(1-2):25-34. PubMed ID: 15817199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
    Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
    Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.